Several studies have shown that Kif18a is a novel biomarker for breast and colorectal cancer [26, 40], and Kif18a overexpression is also associated with unfavorable prognosis in primary hepatocellular carcinoma [16, 19]. This evidence concerns the gene KIF18A and hepatocellular carcinoma.